Detroit, MINCT04458688Now EnrollingIRB Ready

Multiple Sclerosis, Relapsing-Remitting Clinical Trial in Detroit, MI

Access cutting-edge multiple sclerosis, relapsing-remitting treatment through this clinical trial at a research site in Detroit. Study-provided care at no cost to qualified participants.

Sponsored by Wayne State University

Quick Self-Assessment

See if you qualify for this Detroit location

Preparing your pre-screening questions…

Expert Care in Detroit

Access multiple sclerosis, relapsing-remitting specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related multiple sclerosis, relapsing-remitting treatment provided free

Apply for This Detroit Location

Check if you qualify for this multiple sclerosis, relapsing-remitting clinical trial in Detroit, MI

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Detroit

    Convenient for MI residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Detroit site if eligible
  4. 4Begin participation

About This Multiple Sclerosis, Relapsing-Remitting Study in Detroit

The investigators intend to examine the effects of ocrelizumab use in African American multiple sclerosis disease course compared to Caucasian disease course utilizing imaging measures with magnetic resonance imaging (MRI) and optical coherence tomography angiography (OCT-A)..

Sponsor: Wayne State University

Who Can Participate

Inclusion Criteria

Patients who have chosen to start ocrelizumab and for whom ocrelizumab is determined to be the most appropriate standard-of-care disease modifying therapy (DMT) by the treating neurologist.
May be treatment naive, or had suboptimal response to no more than one DMT after an adequate course of treatment (defined as treatment duration of 6+ months).
Age 18 to 60 years old.
Ethnicity: self-identified as African American or Caucasian.
Clinically definite relapsing remitting multiple sclerosis (RRMS) per 2017 revised McDonald criteria.
EDSS from 0 to 6 (inclusive) at baseline visit.
Able to give informed consent.
Able to have MRI scans.

Exclusion Criteria

Treatment with another monoclonal antibody, including but not limited to natalizumab, alemtuzumab, daclizumab.
Failed 2 or more DMTs.
Treatment with immunosuppressant agents, such as chemotherapeutic agents.
Claustrophobia.
Allergy to contrast.
Significant medical problems that the PI determines will interfere with the conduct of the study.
Relapse or use of corticosteroids within 30 days prior to baseline visit.
History of kidney or liver insufficiency.
History of malignancy.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Detroit?

Yes, this clinical trial (NCT04458688) has an active research site in Detroit, MI that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Multiple Sclerosis, Relapsing-Remitting Treatment Options in Detroit, MI

If you're searching for multiple sclerosis, relapsing-remitting treatment options in Detroit, MI, this clinical trial (NCT04458688) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Detroit research site is actively enrolling participants for this clinical trial. You'll receive care from experienced multiple sclerosis, relapsing-remitting specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all multiple sclerosis, relapsing-remitting clinical trials near you to find additional studies recruiting in your area.

More Heart Attack Trials in Detroit, MI

See all heart attack clinical trials recruiting in Detroit — not just this study.

Browse Heart Attack Trials in Detroit →

Browse More Trials by Condition

Heart Attack TrialsMultiple Sclerosis TrialsAntiphospholipid Syndrome TrialsMyocardial Infarction TrialsAll Conditions →

Ready to Join in Detroit?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Detroit, MI